Finding 1166017 (2025-001)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2025
Accepted
2025-12-22
Audit: 376842
Organization: Wheeler Clinic, Inc. (CT)
Auditor: WHITTLESEY PC

AI Summary

  • Core Issue: Significant deficiency in internal controls over payroll, with 12 out of 29 timecards lacking supervisory approval.
  • Impacted Requirements: Salaries charged to government grants must be based on accurately approved time and effort records.
  • Recommended Follow-Up: Implement system changes to prevent payroll processing without supervisor-approved timecards.

Finding Text

Type of Finding: Significant Deficiency in Internal Control over Compliance Criteria: Salaries and wages charged to government grants must be based on records that accurately reflect the work performed. These records must be supported by a system of internal control that provides reasonable assurance that the charges are accurate, allowable, and properly allocated. Additionally, time and effort reporting must be reviewed and approved by a responsible official. Condition: During our testing of payroll processes, we noted that employee timecards were not consistently reviewed or approved by supervisors prior to payroll processing. Of the 29 employees tested requiring timecards, 12 of the sampled timecards lacked documented supervisory approval. Context: Wheeler Clinic, Inc.’s policy requires supervisory approval of timecards, however due to delinquent approvals by supervisors, timecards were processed without approval. Effect: Hourly employees were compensated for hours that were unverified by a direct supervisor and may have been charged to government grants. Cause: There was an override of controls that allowed for processing of the payroll register without approved timecards. Repeat Finding: No Recommendation: We recommend management configure the payroll system to prevent processing of timecards that are not approved by the supervisor. Management’s Response: Wheeler Clinic, Inc. has reviewed the current approval processes. As of October 9, 2025, Wheeler Clinic, Inc. has formally implemented a process change removing any universal approval practices effective immediately. Wheeler Clinic, Inc. has also implemented a process that requires all managers/supervisors to authorize timesheets by a designated time on the subsequent Monday of the payroll cycle prior to payroll processing in order for payroll to be processed.

Corrective Action Plan

Wheeler Clinic, Inc. has reviewed the current approval processes. As of October 9, 2025, Wheeler Clinic, Inc. has formally implemented a process change removing any universal approval practices effective immediately. Wheeler Clinic, Inc. has also implemented a process that requires all managers/supervisors to authorize timesheets by a designated time on the subsequent Monday of the payroll cycle prior to payroll processing in order for payroll to be processed.

Categories

Reporting Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 1165917 2025-001
    Material Weakness Repeat
  • 1165918 2025-001
    Material Weakness Repeat
  • 1165919 2025-001
    Material Weakness Repeat
  • 1165920 2025-001
    Material Weakness Repeat
  • 1165921 2025-001
    Material Weakness Repeat
  • 1165922 2025-001
    Material Weakness Repeat
  • 1165923 2025-001
    Material Weakness Repeat
  • 1165924 2025-001
    Material Weakness Repeat
  • 1165925 2025-001
    Material Weakness Repeat
  • 1165926 2025-001
    Material Weakness Repeat
  • 1165927 2025-001
    Material Weakness Repeat
  • 1165928 2025-001
    Material Weakness Repeat
  • 1165929 2025-001
    Material Weakness Repeat
  • 1165930 2025-001
    Material Weakness Repeat
  • 1165931 2025-001
    Material Weakness Repeat
  • 1165932 2025-001
    Material Weakness Repeat
  • 1165933 2025-001
    Material Weakness Repeat
  • 1165934 2025-001
    Material Weakness Repeat
  • 1165935 2025-001
    Material Weakness Repeat
  • 1165936 2025-001
    Material Weakness Repeat
  • 1165937 2025-001
    Material Weakness Repeat
  • 1165938 2025-001
    Material Weakness Repeat
  • 1165939 2025-001
    Material Weakness Repeat
  • 1165940 2025-001
    Material Weakness Repeat
  • 1165941 2025-001
    Material Weakness Repeat
  • 1165942 2025-001
    Material Weakness Repeat
  • 1165943 2025-001
    Material Weakness Repeat
  • 1165944 2025-001
    Material Weakness Repeat
  • 1165945 2025-001
    Material Weakness Repeat
  • 1165946 2025-001
    Material Weakness Repeat
  • 1165947 2025-001
    Material Weakness Repeat
  • 1165948 2025-001
    Material Weakness Repeat
  • 1165949 2025-001
    Material Weakness Repeat
  • 1165950 2025-001
    Material Weakness Repeat
  • 1165951 2025-001
    Material Weakness Repeat
  • 1165952 2025-001
    Material Weakness Repeat
  • 1165953 2025-001
    Material Weakness Repeat
  • 1165954 2025-001
    Material Weakness Repeat
  • 1165955 2025-001
    Material Weakness Repeat
  • 1165956 2025-001
    Material Weakness Repeat
  • 1165957 2025-001
    Material Weakness Repeat
  • 1165958 2025-001
    Material Weakness Repeat
  • 1165959 2025-001
    Material Weakness Repeat
  • 1165960 2025-001
    Material Weakness Repeat
  • 1165961 2025-001
    Material Weakness Repeat
  • 1165962 2025-001
    Material Weakness Repeat
  • 1165963 2025-001
    Material Weakness Repeat
  • 1165964 2025-001
    Material Weakness Repeat
  • 1165965 2025-001
    Material Weakness Repeat
  • 1165966 2025-001
    Material Weakness Repeat
  • 1165967 2025-001
    Material Weakness Repeat
  • 1165968 2025-001
    Material Weakness Repeat
  • 1165969 2025-001
    Material Weakness Repeat
  • 1165970 2025-001
    Material Weakness Repeat
  • 1165971 2025-001
    Material Weakness Repeat
  • 1165972 2025-001
    Material Weakness Repeat
  • 1165973 2025-001
    Material Weakness Repeat
  • 1165974 2025-001
    Material Weakness Repeat
  • 1165975 2025-001
    Material Weakness Repeat
  • 1165976 2025-001
    Material Weakness Repeat
  • 1165977 2025-001
    Material Weakness Repeat
  • 1165978 2025-001
    Material Weakness Repeat
  • 1165979 2025-001
    Material Weakness Repeat
  • 1165980 2025-001
    Material Weakness Repeat
  • 1165981 2025-001
    Material Weakness Repeat
  • 1165982 2025-001
    Material Weakness Repeat
  • 1165983 2025-001
    Material Weakness Repeat
  • 1165984 2025-001
    Material Weakness Repeat
  • 1165985 2025-001
    Material Weakness Repeat
  • 1165986 2025-001
    Material Weakness Repeat
  • 1165987 2025-001
    Material Weakness Repeat
  • 1165988 2025-001
    Material Weakness Repeat
  • 1165989 2025-001
    Material Weakness Repeat
  • 1165990 2025-001
    Material Weakness Repeat
  • 1165991 2025-001
    Material Weakness Repeat
  • 1165992 2025-001
    Material Weakness Repeat
  • 1165993 2025-001
    Material Weakness Repeat
  • 1165994 2025-001
    Material Weakness Repeat
  • 1165995 2025-001
    Material Weakness Repeat
  • 1165996 2025-001
    Material Weakness Repeat
  • 1165997 2025-001
    Material Weakness Repeat
  • 1165998 2025-001
    Material Weakness Repeat
  • 1165999 2025-001
    Material Weakness Repeat
  • 1166000 2025-001
    Material Weakness Repeat
  • 1166001 2025-001
    Material Weakness Repeat
  • 1166002 2025-001
    Material Weakness Repeat
  • 1166003 2025-001
    Material Weakness Repeat
  • 1166004 2025-001
    Material Weakness Repeat
  • 1166005 2025-001
    Material Weakness Repeat
  • 1166006 2025-001
    Material Weakness Repeat
  • 1166007 2025-001
    Material Weakness Repeat
  • 1166008 2025-001
    Material Weakness Repeat
  • 1166009 2025-001
    Material Weakness Repeat
  • 1166010 2025-001
    Material Weakness Repeat
  • 1166011 2025-001
    Material Weakness Repeat
  • 1166012 2025-001
    Material Weakness Repeat
  • 1166013 2025-001
    Material Weakness Repeat
  • 1166014 2025-001
    Material Weakness Repeat
  • 1166015 2025-001
    Material Weakness Repeat
  • 1166016 2025-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.558 TEMPORARY ASSISTANCE FOR NEEDY FAMILIES $1.05M
93.870 MATERNAL, INFANT AND EARLY CHILDHOOD HOME VISITING GRANT $723,787
93.788 OPIOID STR $284,183
93.493 CONGRESSIONAL DIRECTIVES $278,152
93.268 IMMUNIZATION COOPERATIVE AGREEMENTS $215,938
93.224 HEALTH CENTER PROGRAM (COMMUNITY HEALTH CENTERS, MIGRANT HEALTH CENTERS, HEALTH CARE FOR THE HOMELESS, AND PUBLIC HOUSING PRIMARY CARE) $204,255
84.215 INNOVATIVE APPROACHES TO LITERACY; PROMISE NEIGHBORHOODS; FULL-SERVICE COMMUNITY SCHOOLS; AND CONGRESSIONALLY DIRECTED SPENDING FOR ELEMENTARY AND SECONDARY EDUCATION COMMUNITY PROJECTS $133,581
16.593 RESIDENTIAL SUBSTANCE ABUSE TREATMENT FOR STATE PRISONERS $128,025
93.526 GRANTS FOR CAPITAL DEVELOPMENT IN HEALTH CENTERS $127,974
93.110 MATERNAL AND CHILD HEALTH FEDERAL CONSOLIDATED PROGRAMS $126,690
93.958 BLOCK GRANTS FOR COMMUNITY MENTAL HEALTH SERVICES $92,897
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $82,744
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $80,214
93.387 NATIONAL AND STATE TOBACCO CONTROL PROGRAM $79,860
93.354 PUBLIC HEALTH EMERGENCY RESPONSE: COOPERATIVE AGREEMENT FOR EMERGENCY RESPONSE: PUBLIC HEALTH CRISIS RESPONSE $66,177
93.669 CHILD ABUSE AND NEGLECT STATE GRANTS $43,000
93.527 GRANTS FOR NEW AND EXPANDED SERVICES UNDER THE HEALTH CENTER PROGRAM $40,058
93.991 PREVENTIVE HEALTH AND HEALTH SERVICES BLOCK GRANT $26,431
93.556 MARYLEE ALLEN PROMOTING SAFE AND STABLE FAMILIES PROGRAM $7,629
93.674 JOHN H. CHAFEE FOSTER CARE PROGRAM FOR SUCCESSFUL TRANSITION TO ADULTHOOD $5,000
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $4,754